Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes.
Clin Pharmacol Ther. 2012 Apr;91(4):647-52. doi: 10.1038/clpt.2011.277. Epub 2012 Feb 22.
Clin Pharmacol Ther. 2012.
PMID: 22357454
Clinical Trial.